Analyst Coverage Updates for CoreWeave
Goldman Sachs has upgraded CoreWeave to a 'Buy' rating, while Truist maintains a 'Buy' rating with a price target of $165.
Stocks · News reference
These 3 ETFs Doubled Investors' Money in October as AI Stocks Crashed
Three inverse ETFs surge up to 134% in October as AI infrastructure and quantum computing stocks tumbled. Here's what fueled their spectacular gains.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Stock Market Today, Nov. 6: Iren Soars 20% on Strong AI Cloud Revenue Growth
Iren (IREN) surged 20% after reporting strong Q1 FY27 earnings with AI cloud revenue nearly tripling to $200 million. The company is converting Bitcoin mining operations to AI cloud capacity and secured a five-year contract with 90% GPU prepayments, signaling strong customer demand and capital efficiency. However, execution risks remain as Microsoft-requested networking changes previously delayed a $9.7 billion AI project.
HC Wainwright & Co. Maintains Buy on IREN, Lowers Price Target to $56
ARK Invest Sells 412,666 Shares of CoreWeave
ARK Invest, led by Cathie Wood, sold 412,666 shares of CoreWeave, Inc. valued at approximately $20 million.
AI Stocks Got Hammered After Midterms, but This Analyst Says the Panic Is Overblown
Bernstein calls the AI data center stock drop overblown, forecasting just a 2% to 4% national capacity impact post-elections.
IREN Q1 Earnings Call Highlights AI Growth and Deployment Delays
IREN Limited reported Q1 FY2027 results with AI cloud revenues of $200 million (182% sequential growth) and a $20 billion revenue backlog. However, the company pushed its $4 billion operating ARR target from December 2026 to January 2027 due to customer-requested design changes and supplier delays. Management also reduced capital expenditure plans to $15 billion for the remainder of fiscal 2027, citing financing conditions rather than weakening demand. The company carries a Zacks Rank #4 (Sell) rating.